JOHN WAYNE CANCER INSTITUTE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 14111
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1188
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594
 
  
 
C12M APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY 445
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4202
 
  
 
C07K PEPTIDES 2134
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9758829 Molecular malignancy in melanocytic lesionsJun 24, 13Sep 12, 17[C12Q]
9567640 Utility of B-RAF DNA mutation in diagnosis and treatment of cancerMay 11, 12Feb 14, 17[C12Q]
9556491 Utility of B-RAF DNA mutation in diagnosis and treatment of cancerFeb 26, 08Jan 31, 17[A61K, C12Q]
9410206 Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancerNov 30, 12Aug 09, 16[C12Q]
9162884 Method and apparatus for in vivo surveillance of circulating biological componentsDec 21, 11Oct 20, 15[B82Y, C12M, G01N]
9156898 Treatment of cancer and compositionsSep 23, 11Oct 13, 15[C12Q, C07K]
9074253 Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer typesSep 27, 13Jul 07, 15[C12Q]
8569044 Method and apparatus for in vivo collection of circulating biological componentsAug 08, 11Oct 29, 13[C12M]
8288099 Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancerDec 14, 09Oct 16, 12[C07H, C12Q]
8084246 Method and apparatus for in vivo surveillance of circulating biological componentsApr 24, 08Dec 27, 11[C12M]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0071,852 FOXC1 ANTIBODIES AND METHODS OF THEIR USEAbandonedApr 10, 14Mar 12, 15[A61K, G01N, C07K]
2014/0206,961 METHOD AND APPARATUS FOR IN VIVO COLLECTION OF CIRCULATING BIOLOGICAL COMPONENTSAbandonedOct 28, 13Jul 24, 14[A61B]
2013/0345,144 Use of ID4 for Diagnosis and Treatment of CancerAbandonedAug 07, 09Dec 26, 13[G01N]
2013/0323,740 DIRECT BLOOD ASSAY FOR DETECTION OF CIRCULATING MICRORNA IN CANCER PATIENTSAbandonedMar 22, 13Dec 05, 13[C12Q]
2013/0231,259 Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCRAbandonedDec 11, 12Sep 05, 13[C12Q]
2012/0148,561 USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETSAbandonedFeb 17, 12Jun 14, 12[A61K, C12N, A61P]
2012/0088,683 Detection of Cancer Cells in Body FluidsAbandonedOct 02, 11Apr 12, 12[C40B]
2011/0206,705 B7-H3 AS A BIOMARKER FOR DIAGNOSING THE PROGRESSION AND EARLY LYMPH NODE METASTASIS OF CANCERAbandonedDec 27, 10Aug 25, 11[A61K, C12Q, G01N, A61P]
2011/0207,136 Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCRAbandonedJan 12, 11Aug 25, 11[C12Q]
2011/0150,979 METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PRIMARY AND METASTATIC BASAL-LIKE BREAST CANCER AND OTHER CANCER TYPESAbandonedAug 07, 10Jun 23, 11[A61K, C12Q, A61P]
2010/0227,319 USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETSAbandonedJun 18, 09Sep 09, 10[C12Q, C12N, G01N]
2010/0068,743 Method for predicting response of cancer patient to anticancer drug treatmentAbandonedSep 02, 09Mar 18, 10[C12Q]
2010/0003,689 Use of Methylation Status of MINT Loci as a Marker for Rectal CancerAbandonedJun 19, 09Jan 07, 10[C12Q]
2009/0280,479 USE OF FREE CIRCULATING DNA FOR DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER FUNDINGAbandonedMay 30, 06Nov 12, 09[C12Q]
2009/0220,980 USE OF METHYLATION STATUS OF MINT LOCI AND TUMOR-RELATED GENES AS A MARKER FOR MELANOMA AND BREAST CANCERAbandonedDec 24, 08Sep 03, 09[C12Q]
2009/0068,660 USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKERAbandonedApr 25, 08Mar 12, 09[C12Q]
2009/0028,866 USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINEAbandonedJul 27, 07Jan 29, 09[A61K, C12Q, G01N, A61P]
2009/0011,418 FUNCTIONAL TOLL-LIKE RECEPTORS (TLR) ON MELANOCYTES AND MELANOMA CELLS AND USES THEREOFAbandonedApr 24, 08Jan 08, 09[C12Q, C12N, G01N]
2008/0076,727 UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCERAbandonedMar 29, 07Mar 27, 08[A61K, C12Q, C12N, C12M, G01N, A61P, C07K]
2007/0031,867 Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcomeAbandonedJun 27, 06Feb 08, 07[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.